ProQR Therapeutics N.V. (PRQR) NASDAQ
1.47
+0.05(+3.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.47
+0.05(+3.52%)
Currency In USD
| Market Cap | 181.09M |
| Enterprise Value | 102.7M |
| P/E Ratio | -2.92 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 9.91 |
| Price/Book Ratio | 3.54 |
| Enterprise/Revenue | 4.89 |
| Enterprise/EBITDA | -1.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -3.39 |
| Operating Margin | -3.46 |
| Return On Assets | -0.46 |
| Return On Equity | -0.86 |
| Revenue | 15.28M |
| Revenue/Share | 0.13 |
| Gross Profit | 12.68M |
| EBITDA | -39.56M |
| Net Income | -40.52M |
| Diluted EPS | -0.38 |
| Total Cash | 81.17M |
| Total Cash/Share | 0.77 |
| Total Debt | 13.7M |
| Total Debt/Equity | 0.36 |
| Current Ratio | 2.48 |
| Book Value Per Share | 0.36 |
| 52-Week Change | -17.42 |
| 52-Week High | 3.1 |
| 52-Week Low | 1.33 |
| Moving Average 50 Days | 1.64 |
| Moving Average 200 Days | 1.95 |
| Average Volume | 606,561 |
| Shares Outstanding | 105.36M |
| % Held by Institutions | 34.06 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |